Glucose Intolerance Clinical Trial
Official title:
Clinical Utility of Carbohydrate Breath Tests in Unexplained GI Symptoms
Bloating, gas, pain and diarrhea are common complaints. Routine investigations are negative; these patients are labeled as IBS. In these patients, whether testing for carbohydrate malabsorption or small intestinal bacterial overgrowth (SIBO) is useful is unclear. Investigators aim to assess the prevalence of SIBO, fructose and lactose intolerance, the usefulness of breath tests, and predictive value of pre-test symptoms.
Abdominal bloating, gas, belching, distension, and diarrhea are common gastrointestinal
symptoms that are reported by at least 1/3rd of patients presenting to gastroenterology
clinics. When routine endoscopic and radiological tests are negative1, most of these patients
are labeled as irritable bowel syndrome (IBS) in gastroenterology practice2. Unfortunately
these symptoms persist and these patients remain dissatisfied with their health care and
continue to doctor shops or seek remedies from alternative care. Several studies have shown
that these symptoms have a significant and negative impact on their quality of life. One
possible explanation for their symptom is carbohydrate food intolerance. The Western diet has
changed significantly over the last 3 decades. Today, large amounts of fructose are being
consumed. This sugar is used as a sweetener in sodas, fruit juices, multiples beverages and
candies. Although is naturally present in apples, peaches, pears and oranges, the exponential
products and consumption of the synthetic high fructose corn syrup has alarmingly increased
fructose consumption. When small amounts are ingested, fructose is completely absorbed from
the gut mainly through Glut 5transporter from the intestinal brush border or through
facilitated transport along glucose through the Glut 2 transporter5. If a person has either
limited absorptive capacity or overwhelms normal absorption capacity by excess ingestion,
then malabsorption of fructose ensues. This unabsorbed fructose can serve, as an osmotic
load, that draws fluid into the intestinal lumen, causing abdominal bloating, gas, pain and
diarrhea 6-7. Likewise lactose is a disaccharide that is present in dairy products and is
widely consumed. After ingestion lactose is hydrolyzed in the small intestine by the brush
border enzyme lactase into glucose and galactose that are in torn absorbed8. If lactose is
malabsorbed by Glut 2, then it will serve as an osmotic load, and get rapidly propelled in to
the colon where it is fermented by the colonic bacterial flora, into short chain fatty acid,
hydrogen,methane and other gases, this lactose malabsorption produces gas, bloating,
flatulence and diarrhea9. About 75% of the world´s population gradually lose their ability to
produce the lactase enzyme after age 30 years10-11.
Malabsorption or intolerance of carbohydrates such as fructose and lactose are common and
frequently encountered both in the primary care and specialist gastroenterology clinics, but
are poorly recognized or treated. Over the last decade, breath testing has emerged as a
simple, non invasive method of identifying malabsorption and/ or intolerance to common food
ingredients such as fructose12, and lactose13, as well as to identify small intestinal
bacterial overgrowth (SIBO)14. However, they are only performed in selected academic centers,
and their clinical utility and diagnostic yield largely remains unknown.
Also may the clinical utility of performing a single breath test versus a cumulative battery
of breath tests, such as glucose, lactose or fructose breath test, in a patient with
unexplained GI symptoms is also not known.
The aims of this study are to investigate a consecutive series of patients with unexplained
chronic GI symptoms and examine; 1) the prevalence of SIBO answered by the glucose breath
test, fructose and lactose intolerance answered by the fructose y lactose breath test, ; 2)
the predictive value of pre-test symptoms in the diagnosis of SIBO or carbohydrate
intolerance.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05544266 -
Rare and Atypical Diabetes Network
|
||
Completed |
NCT03241121 -
Study of Eating Patterns With a Smartphone App and the Effects of Time Restricted Feeding in the Metabolic Syndrome
|
N/A | |
Completed |
NCT03809182 -
Effect of Dexmedetomidine on Postoperative Glucose and Insulin Levels.
|
Phase 4 | |
Completed |
NCT03675360 -
Low-Carbohydrate Dietary Pattern on Glycemic Outcomes Trial
|
N/A | |
Completed |
NCT01671293 -
Multicomponent Telecare Model for Supporting Prediabetes Patients
|
N/A | |
Not yet recruiting |
NCT01402362 -
Prevalence of Glucose Intolerance and Risk Factors in Ethiopian Immigrants in Israel; Follow-up Study.
|
N/A | |
Completed |
NCT00740363 -
Sitagliptin in Renal Transplant Recipients
|
Phase 4 | |
Completed |
NCT00436475 -
Vitamin D and Calcium Homeostasis for Prevention of Type 2 Diabetes
|
Phase 1/Phase 2 | |
Completed |
NCT04090788 -
The Effect of Momordica Charantia Supplementation on Blood Glucose Levels
|
N/A | |
Active, not recruiting |
NCT05460884 -
Effects of Seaweed Extract on Postprandial Response to White Bread
|
N/A | |
Not yet recruiting |
NCT05462834 -
Impact of Nocturnal Hypoxemia on Glucose in High Altitude Sleep Disordered Breathing
|
N/A | |
Completed |
NCT03348020 -
Iron and Insulin Resistance in Overweight and Obese Humans
|
N/A | |
Terminated |
NCT03356873 -
Impact of Correction of Vitamin D Deficiency in Oxidative Stress in Patients With Prediabetes (VICOX)
|
N/A | |
Completed |
NCT03922685 -
Effects of Diet and Exercise on Circadian Glycemia
|
N/A | |
Completed |
NCT03730727 -
Exercise-meal Timing and Postprandial Glucose Control
|
N/A | |
Completed |
NCT04743960 -
Assessing Metabolic and Sleep Consequences of Overnight Home Parenteral Nutrition
|
N/A | |
Completed |
NCT04004273 -
Diabetes, Exercise and Liver Fat (DELIVER)
|
N/A | |
Completed |
NCT02412995 -
The Effects of Sea Buckthorn and Strawberry on Postprandial Glycaemia, Insulinemia and Appetite
|
Phase 0 | |
Terminated |
NCT01887691 -
Sleep Effectiveness and Insulin and Glucose Homeostasis
|
Phase 1 | |
Not yet recruiting |
NCT01436448 -
Probiotics (Lactobacillus Rhamnosus) in Reducing Glucose Intolerance During and After Pregnancy
|
Phase 3 |